Androgen and Wnt signaling in bladder cancer
膀胱癌中的雄激素和 Wnt 信号传导
基本信息
- 批准号:10727745
- 负责人:
- 金额:$ 21.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdenineAdultAndrogen ReceptorAndrogensBacterial DNABinding ProteinsBiologicalBiological AssayBladderBladder NeoplasmCancer ModelCarcinogensCell ProliferationChemicalsChimeric ProteinsComplexDNADNA-Binding ProteinsDevelopmentEP300 geneEmbryoEnzymesEpitheliumGene ExpressionGenesGenetic TranscriptionGenitalGenitaliaGenitourinary systemGonadal Steroid HormonesIncidenceKnowledgeLaboratoriesLower urinary tractMalignant NeoplasmsMalignant neoplasm of urinary bladderMammalian CellMapsMasculineMethylationModelingMolecularOrganoidsPathway interactionsPhysiologicalPlayPredispositionProteinsProtocols documentationPublicationsPublishingRecording of previous eventsReportingResearchRodentRoleSex BiasSex ChromosomesSex DifferencesSignal TransductionSite-Specific DNA-Methyltransferase (Adenine-Specific)Small Interfering RNASmokingTechnologyTestingTransgenic MiceTransgenic ModelTransgenic OrganismsUrotheliumWNT Signaling PathwayWomanbeta catenincancer initiationcarcinogenesisclinically relevantimprovedin vivomalemenprotein complexreconstitutionsextooltranscription factortranscriptome sequencing
项目摘要
ABSTRACT
Bladder cancer is the 4th most common cancer in men and 11th in women. Despite that bladder
development and function are not sex hormone-dependent, men are three times more likely to develop
bladder cancer than women. Smoking has been shown not to be a contributor for this gender bias. Instead,
intrinsic sex-differences likely underpin the molecular mechanism for male susceptibility to bladder cancer.
Sex hormones and sex chromosomes are obvious suspects to account for this male predilection for
bladder cancer. In fact, experimental evidence in rodents strongly support a crucial role for androgen
receptor in promoting cancer development in a chemical-induced bladder cancer model. In addition to
androgen signaling, the other undeniably powerful regulator of lower urinary tract development and
carcinogenesis is the WNT signaling pathway. β-catenin is the signal integrator of canonical WNT signaling
and AR and β-catenin physically interact to synergistically activate transcription. This interaction is crucial
for downstream target expression during genital masculinization, bladder cancer development and
progression. Despite the crucial roles these two pathways play in bladder carcinogenesis, their direct
transcriptional targets, which are likely drivers of bladder cancer initiation, remain elusive. In this
application, we propose to use a recently developed powerful technology, Split DamID to reveal in vivo
transcriptional targets downstream of AR, p300 and β-catenin during bladder cancer development. In Aim
1, we will use our newly generated transgenic model to reveal direct AR and p300 transcriptional targets in
a carcinogen-induced bladder cancer model. Next, in Aim 2, we will use SpDamID on bladder organoids to
reveal AR and β-catenin direct targets, followed by siRNA functional screen for their roles in promoting
organoid formation. Together, these studies should greatly improve our understanding of bladder cancer
initiation, especially those controlled by AR and Wnt signaling.
摘要
膀胱癌是男性第4大常见癌症,女性第11大常见癌症。尽管膀胱
发育和功能不依赖于性别,男性比男性更有可能发展三倍
膀胱癌的发病率更高。吸烟已被证明不是这种性别偏见的贡献者。相反地,
内在的性别差异可能是男性易患膀胱癌的分子机制的基础。
性激素和性染色体是解释这种男性偏好的明显嫌疑人。
膀胱癌事实上,啮齿类动物的实验证据强烈支持雄激素的关键作用,
受体在化学诱导的膀胱癌模型中促进癌症发展的作用。除了
雄激素信号传导,另一个强有力的下尿路发育调节因子,
致癌作用是WNT信号通路。β-catenin是经典WNT信号传导的信号整合剂
AR和β-连环蛋白物理相互作用以协同激活转录。这种互动至关重要
在生殖器男性化、膀胱癌发展和
进展尽管这两种途径在膀胱癌发生中起着至关重要的作用,但它们的直接
可能是膀胱癌起始驱动因素的转录靶点仍然难以捉摸。在这
应用程序,我们建议使用最近开发的强大技术,分裂DamID揭示体内
在膀胱癌发展过程中,AR、p300和β-连环蛋白下游的转录靶点。在Aim中
1,我们将使用我们新产生的转基因模型来揭示AR和p300的直接转录靶点。
致癌物诱发的膀胱癌模型。接下来,在目标2中,我们将在膀胱类器官上使用SpDamID,
揭示AR和β-catenin的直接靶点,然后通过siRNA功能筛选它们在促进
类器官形成总之,这些研究应该大大提高我们对膀胱癌的认识
启动,特别是那些由AR和Wnt信号转导控制的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liang Ma其他文献
Liang Ma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liang Ma', 18)}}的其他基金
GENOME-WIDE IDENTIFICATION OF GENES REQUIRED FOR DECIDUALIZATION
蜕化所需基因的全基因组鉴定
- 批准号:
9258455 - 财政年份:2016
- 资助金额:
$ 21.37万 - 项目类别:
GENERATION OF AN INDUCIBLE SYSTEM IN THE UTERINE STROMA FOR IMPLANTATION STUDIES
用于植入研究的子宫间质中诱导系统的生成
- 批准号:
8358586 - 财政年份:2012
- 资助金额:
$ 21.37万 - 项目类别:
GENERATION OF AN INDUCIBLE SYSTEM IN THE UTERINE STROMA FOR IMPLANTATION STUDIES
用于植入研究的子宫间质中诱导系统的生成
- 批准号:
8522211 - 财政年份:2012
- 资助金额:
$ 21.37万 - 项目类别:
Novel effectors of ERK signaling and their potential roles in the treatment of en
ERK 信号传导的新型效应物及其在治疗 en 中的潜在作用
- 批准号:
7727351 - 财政年份:2009
- 资助金额:
$ 21.37万 - 项目类别:
相似海外基金
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 21.37万 - 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
- 批准号:
10534031 - 财政年份:2022
- 资助金额:
$ 21.37万 - 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
- 批准号:
10794933 - 财政年份:2022
- 资助金额:
$ 21.37万 - 项目类别:
Development of nobel assay methods for miRNA and adenine methyltransferase using FRET
使用 FRET 开发 miRNA 和腺嘌呤甲基转移酶的诺贝尔检测方法
- 批准号:
21K05120 - 财政年份:2021
- 资助金额:
$ 21.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's disease
健康老龄化和阿尔茨海默病脑细胞 DNA 腺嘌呤甲基化的批判性评估
- 批准号:
10365337 - 财政年份:2021
- 资助金额:
$ 21.37万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10033546 - 财政年份:2020
- 资助金额:
$ 21.37万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10613902 - 财政年份:2020
- 资助金额:
$ 21.37万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10396102 - 财政年份:2020
- 资助金额:
$ 21.37万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10226235 - 财政年份:2020
- 资助金额:
$ 21.37万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10705982 - 财政年份:2020
- 资助金额:
$ 21.37万 - 项目类别:














{{item.name}}会员




